We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ADTRAN Unveils NetAssure Program to Aid Network Operators
Read MoreHide Full Article
ADTRAN, Inc. (ADTN - Free Report) recently unveiled NetAssure Service Program as part of its growing consulting services. The venture, which has been designed to help network operators reduce operational costs of managing the range of today’s networks infrastructures, is rapidly becoming a significant part of the company’s current customer engagement model.
The program entails evaluation of network infrastructure and risk assessment of the current state of network. It helps network operators integrate new technologies for expansion, and supports rural carriers to help evolve their network. It utilizes software-based tools that leverage leading cloud infrastructure to process the extensive data sets. ADTRAN’s NetAssure Program is expected to help customers pair the best technologies with their unique network, lower operational costs and exceed subscriber expectations.
At the same time, the networking and communications equipment provider announced that operators have started realizing the value of a platform approach as the company is helping them build Gigabit networks with Mosaic Cloud Platform. The Mosaic Subscriber Experience tools provide advanced analytics, software centric operations and virtualized service delivery.
ADTRAN is accelerating the industry’s transition to open, programmable, scalable networks by leveraging the ADTRAN Mosaic Software-Defined Access architecture that combines modern Web-scale technologies with open-source platforms to facilitate rapid innovation in multi-technology, multi-vendor environments. The Mosaic cloud platform and Mosaic OS, combined with programmable network elements, provide operators with a highly agile, open-services architecture. This allows operators to better face Web-scale competition by reducing the time and cost to on-board new service, technologies and best-of-breed suppliers as they strive to reduce operational costs while creating and deploying differentiated product offerings.
The company is focused on becoming a top global supplier of Access infrastructure and related value-added solutions from the Cloud Edge to the Subscriber Edge through a broad portfolio of flexible hardware and software network solutions. These products enable customers to transition to the fully converged, scalable, highly automated, cloud-controlled voice, data, Internet and video network.
Over the past three months, shares of ADTRAN have outperformed the industry with an average return of 13% compared with 4.1% growth for the latter.
ADTRAN currently has a Zacks Rank #3 (Hold). Better-ranked stocks in the broader industry include United States Cellular Corporation (USM - Free Report) , AT&T Inc. (T - Free Report) and Windstream Holdings, Inc. . While United States Cellular and AT&T sport a Zacks Rank #1 (Strong Buy), Windstream carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
United States Cellular has a long-term earnings growth expectation of 1%. It surpassed earnings estimates thrice in the trailing four quarters with an average positive surprise of 303.6%.
AT&T has a long-term earnings growth expectation of 3.6%. It surpassed earnings estimates twice in the trailing four quarters with an average positive surprise of 5.9%.
Windstream surpassed earnings estimates twice in the trailing four quarters with an average positive surprise of 23.5%.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
ADTRAN Unveils NetAssure Program to Aid Network Operators
ADTRAN, Inc. (ADTN - Free Report) recently unveiled NetAssure Service Program as part of its growing consulting services. The venture, which has been designed to help network operators reduce operational costs of managing the range of today’s networks infrastructures, is rapidly becoming a significant part of the company’s current customer engagement model.
The program entails evaluation of network infrastructure and risk assessment of the current state of network. It helps network operators integrate new technologies for expansion, and supports rural carriers to help evolve their network. It utilizes software-based tools that leverage leading cloud infrastructure to process the extensive data sets. ADTRAN’s NetAssure Program is expected to help customers pair the best technologies with their unique network, lower operational costs and exceed subscriber expectations.
At the same time, the networking and communications equipment provider announced that operators have started realizing the value of a platform approach as the company is helping them build Gigabit networks with Mosaic Cloud Platform. The Mosaic Subscriber Experience tools provide advanced analytics, software centric operations and virtualized service delivery.
ADTRAN is accelerating the industry’s transition to open, programmable, scalable networks by leveraging the ADTRAN Mosaic Software-Defined Access architecture that combines modern Web-scale technologies with open-source platforms to facilitate rapid innovation in multi-technology, multi-vendor environments. The Mosaic cloud platform and Mosaic OS, combined with programmable network elements, provide operators with a highly agile, open-services architecture. This allows operators to better face Web-scale competition by reducing the time and cost to on-board new service, technologies and best-of-breed suppliers as they strive to reduce operational costs while creating and deploying differentiated product offerings.
The company is focused on becoming a top global supplier of Access infrastructure and related value-added solutions from the Cloud Edge to the Subscriber Edge through a broad portfolio of flexible hardware and software network solutions. These products enable customers to transition to the fully converged, scalable, highly automated, cloud-controlled voice, data, Internet and video network.
Over the past three months, shares of ADTRAN have outperformed the industry with an average return of 13% compared with 4.1% growth for the latter.
ADTRAN currently has a Zacks Rank #3 (Hold). Better-ranked stocks in the broader industry include United States Cellular Corporation (USM - Free Report) , AT&T Inc. (T - Free Report) and Windstream Holdings, Inc. . While United States Cellular and AT&T sport a Zacks Rank #1 (Strong Buy), Windstream carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
United States Cellular has a long-term earnings growth expectation of 1%. It surpassed earnings estimates thrice in the trailing four quarters with an average positive surprise of 303.6%.
AT&T has a long-term earnings growth expectation of 3.6%. It surpassed earnings estimates twice in the trailing four quarters with an average positive surprise of 5.9%.
Windstream surpassed earnings estimates twice in the trailing four quarters with an average positive surprise of 23.5%.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>